|
From
biopiracy to bioprosperity
Age-old remedies are part of boardroom presentations today,
as pharmaceutical companies tap tradition, searching for the
next blockbuster molecule. Is this biopiracy or bioprospecting?
Sachin Jagdale analyses
Pricing
plays in major pharma markets
Governments across the world are employing various pricing
and reimbursement control measures to keep the cost of healthcare
down and the Indian government may have to make similar decisions
in the near future. What will be the impact and reaction of
these pricing plays on pharmaceutical players?
Safety
in automation
New technology and global standards help to ensure a safe
workplace, boost productivity, and reduce environmental impact
Environmental
risk assessment for pharmaceuticals
The EU and US have already established regulations concerning
environmental risk assessment (ERA) for pharmaceuticals
Cognis
strengthens pharmaceutical drug delivery platform with Vitamin
E TPGS
Global specialty chemicals supplier Cognis will start with
the production of TPGS (D-alpha Tocopheryl Polyethylene Glycol
1000 Succinate) that meets the market standards in terms of
composition and manufacturing technology
Johnson
& Johnson honours 2008 recipients of The Dr Paul Janssen
Award
The 2008 recipients of The Dr Paul Janssen Award for Biomedical
Research, Professor Marc Feldmann, FMedSci, FAA, FRS and Emeritus
Professor Sir Ravinder Maini, FRCP, FMedSci, FRS of the Kennedy
Institute of Rheumatology, Imperial College London, were honoured
during a scientific symposium and at a formal award ceremony
at the Dr Paul Janssen Research Center in Beerse, Belgium
Safexpress’
take on controlling logistics inflation
Safexpress elucidated on the 'Strategies to control costs
in spite of inflation' at a conference on 'Controlling logistics
inflation'
HIV-I
drug resistance assay from geneOmbio Technologies
Due to the availability of a large number of antiviral drugs,
the mortality and morbidity associated with Human Immunodeficiency
Virus (HIV) has decreased significantly even in developing
countries like India
Products
Successful
LIMS require a long-term partnership
Over the last six years LabWare have invested in India and
established an experienced LIMS technical team that have successfully
installed and support LIMS in India and the surrounding regions.
This article by Nick Townsend, Director Life Sciences, discusses
the philosophy behind LabWare's approach to the Indian and
global LIMS market
|
